Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mateya Trinkaus"'
Autor:
Tracy L. Stockley, Amit M. Oza, Hal K. Berman, Natasha B. Leighl, Jennifer J. Knox, Frances A. Shepherd, Eric X. Chen, Monika K. Krzyzanowska, Neesha Dhani, Anthony M. Joshua, Ming-Sound Tsao, Stefano Serra, Blaise Clarke, Michael H. Roehrl, Tong Zhang, Mahadeo A. Sukhai, Nadia Califaretti, Mateya Trinkaus, Patricia Shaw, Theodorus van der Kwast, Lisa Wang, Carl Virtanen, Raymond H. Kim, Albiruni R. A. Razak, Aaron R. Hansen, Celeste Yu, Trevor J. Pugh, Suzanne Kamel-Reid, Lillian L. Siu, Philippe L. Bedard
Publikováno v:
Genome Medicine, Vol 8, Iss 1, Pp 1-12 (2016)
Abstract Background The clinical utility of molecular profiling of tumor tissue to guide treatment of patients with advanced solid tumors is unknown. Our objectives were to evaluate the frequency of genomic alterations, clinical “actionability” o
Externí odkaz:
https://doaj.org/article/2324a93386cd465198309a40f8651cb5
Autor:
Vicky Tagalakis, Mateya Trinkaus, Ranjeeta Mallick, Grégoire Le Gal, Alejandro Lazo-Langner, Ariah Schattner, Philip Kuruvilla, Katerine Marquis, Karim Abou-Nassar, David J. Stewart, Marc Carrier, Debra Witham, Silvana Spadafora, Philip S. Wells, Agnes Y.Y. Lee, Glenwood D. Goss, Sudeep Shivakumar, Avert Investigators, Peter L. Gross, Marc A. Rodger, Danny Hill, Robert El-Maraghi, Anna Tomiak, Tim Ramsay
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2019, 380 (8), pp.711-719. ⟨10.1056/NEJMoa1814468⟩
New England Journal of Medicine, Massachusetts Medical Society, 2019, 380 (8), pp.711-719. ⟨10.1056/NEJMoa1814468⟩
Patients with active cancer have an increased risk of venous thromboembolism, which results in substantial morbidity, mortality, and health care expenditures. The Khorana score (range, 0 to 6, with higher scores indicating a higher risk of venous thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90d64df22ff5f5100f5d840f3863a81
https://hal.univ-brest.fr/hal-02052475
https://hal.univ-brest.fr/hal-02052475
Autor:
Nadia Califaretti, Lillian L. Siu, Neesha C. Dhani, Mateya Trinkaus, Trevor J. Pugh, Carl Virtanen, Tong Zhang, Theodorus van der Kwast, Blaise A. Clarke, Eric X. Chen, Albiruni Ryan Abdul Razak, Natasha B. Leighl, Mahadeo A. Sukhai, Hal K. Berman, Michael H.A. Roehrl, Anthony M. Joshua, Patricia Shaw, Amit M. Oza, Ming-Sound Tsao, Monika K. Krzyzanowska, Suzanne Kamel-Reid, Aaron R. Hansen, Frances A. Shepherd, Lisa Wang, Raymond H. Kim, Jennifer J. Knox, Stefano Serra, Tracy Stockley, Philippe L. Bedard, Celeste Yu
Publikováno v:
Genome Medicine
Genome Medicine, Vol 8, Iss 1, Pp 1-12 (2016)
Genome Medicine, Vol 8, Iss 1, Pp 1-12 (2016)
Background The clinical utility of molecular profiling of tumor tissue to guide treatment of patients with advanced solid tumors is unknown. Our objectives were to evaluate the frequency of genomic alterations, clinical “actionability” of somatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03daf5b77d90ab405e770aa3e78e25e
http://europepmc.org/articles/PMC5078968
http://europepmc.org/articles/PMC5078968
Autor:
Stockley, Tracy, Oza, Amit, Berman, Hal, Leighl, Natasha, Knox, Jennifer, Shepherd, Frances, Chen, Eric, Krzyzanowska, Monika, Neesha Dhani, Joshua, Anthony, Ming-Sound Tsao, Serra, Stefano, Clarke, Blaise, Roehrl, Michael, Zhang, Tong, Mahadeo Sukhai, Califaretti, Nadia, Mateya Trinkaus, Shaw, Patricia, Kwast, Theodorus Van Der, Wang, Lisa, Virtanen, Carl, Kim, Raymond, Albiruni Razak, Hansen, Aaron, Yu, Celeste, Pugh, Trevor, Kamel-Reid, Suzanne, Siu, Lillian, Bedard, Philippe
Supplementary methods and Tables S1â S4. (DOCX 148 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096736100b8f0b651d302320fefec04d
Publikováno v:
Supportive Care in Cancer. 18:197-203
Clinical trials exploring bisphosphonate (BP) use in patients with bone metastases from breast cancer (BC) consistently state skeletal-related event (SRE) rates50%. These trials predominantly include patients with bone only disease, and also frequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2e6c4817d22aa883c81428def279d0
https://doi.org/10.1007/s00520-009-0645-z
https://doi.org/10.1007/s00520-009-0645-z
Autor:
Eric Chen, Mahadeo A. Sukhai, Tong Zhang, Blaise Clarke, Amit M. Oza, Trevor J. Pugh, Hal K. Berman, Lillian L. Siu, Philippe L. Bedard, Michael H.A. Roehrl, Ming-Sound Tsao, Suzanne Kamel-Reid, Albiruni Ryan Abdul Razak, Nadia Califaretti, Stefano Serra, Anca Milea, Tracy Stockley, Natasha B. Leighl, Mateya Trinkaus, Aaron R. Hansen
Publikováno v:
Clinical Cancer Research. 22:PR03-PR03
Background: IMPACT and COMPACT are ongoing clinical trials at Princess Margaret (PM) to match advanced solid tumor patients with actionable somatic mutations to clinical trials with investigational therapies [NCT01505400]. We compared the outcome of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52869ac2f4a80e1a6efdcc62e7b7575e
https://doi.org/10.1158/1557-3265.pmsclingen15-pr03
https://doi.org/10.1158/1557-3265.pmsclingen15-pr03
Publikováno v:
Current Oncology
Volume 15
Issue 3
Pages 233-154
Volume 15
Issue 3
Pages 233-154
Sunitinib (Sutent: Pfizer, New York, NY, U.S.A.) is an oral multi-targeted tyrosine kinase inhibitor approved for use in various solid tumour malignancies. Many side effects secondary to sunitinib have been documented. In particular, sunitinib admini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aee3f73ffb67cd673d564eafbf614ca3
https://doi.org/10.3747/co.v15i3.233
https://doi.org/10.3747/co.v15i3.233
Autor:
Niusha Barmala, Mateya Trinkaus, Christopher Lo, Camilla Zimmermann, Jennifer M. Jones, Debika Burman, Gary Rodin
Publikováno v:
Psycho-oncology. 20(7)
Objective: Complementary and alternative medicine (CAM) is frequently used by patients with advanced cancer, for a variety of reasons. We examined the use of CAM in this population, and associations of use for potential cure with spiritual faith and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d360c959f544bf0667ab0ec21ca27d0b
https://pubmed.ncbi.nlm.nih.gov/20878865
https://pubmed.ncbi.nlm.nih.gov/20878865
Autor:
Sheray N. Chin, Mateya Trinkaus, Mark Clemons, Christine Simmons, Robyn Bolivar, Candi Flynn, George Dranitsaris
Publikováno v:
Clinical breast cancer. 9(2)
Background: Data from randomized trials in postmenopausal women receiving endocrine therapy for breast cancer would suggest that the incidence of significant urogenital symptoms is around 40%. As there are inherent reporting biases associated with cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dad5495b0d33c3af99495c18fd241b98
https://pubmed.ncbi.nlm.nih.gov/19433392
https://pubmed.ncbi.nlm.nih.gov/19433392
Autor:
Mateya Trinkaus, Marion Kalina, Snezana Popovic, Hariette Kahn, Ethan Amir, Mark Clemons, Mary C Gainford, Wei Seong Ooi, Gurmit Singh
Publikováno v:
Oncology Reports. 21
The benefits of bisphosphonates (BPs) in reducing skeletal-related events (SREs) in patients with bone metastases has mainly been attributed to their potent osteoclast inhibiting effect. However, despite the use of modern systemic anticancer therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552786cac6c497b0abc2406590c30d00
https://doi.org/10.3892/or_00000335
https://doi.org/10.3892/or_00000335